Veterinary Antibiotics Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 3.90 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Veterinary Antibiotics Market Analysis
The veterinary antibiotics market is expected to register a CAGR of 3.9% over the forecast period.
The demand for veterinary antibiotics was severely hampered due to the significant impact on veterinary practice during the lockdown period. The diagnosis rate of veterinary infection declined during the initial phase of the COVID-19 pandemic. The strict lockdown imposed in the majority of the countries was responsible for the negative impact on the veterinary practice along with the decline in demand for veterinary drugs including veterinary antibiotics. According to the study published by the British Veterinary Association, in May 2022, 32.8% of pet owners recorded difficulties in accessing veterinary healthcare during the initial phase of the COVID-19 lockdown. Veterinary healthcare facilities were open for emergency procedures however most of the prophylactic treatments were delayed for the animals.
Moreover, the disruption in the supply chain of veterinary pharmaceutical products, along with the reallocation of veterinarians for the management of COVID-19 had a significant impact on veterinary treatment which significantly hampered the market growth. Due to the above-mentioned factors, the majority of veterinary pharmaceutical companies recorded a significant decline in product sales during the COVID-19 pandemic.
Furthermore, the increasing number of animal health concerns along with the growing awareness about veterinary diseases is anticipated to drive the adoption of veterinary antibiotics during the forecast period. The growing number of livestock in developing as well as developed countries are also supporting market growth. According to the data published by, Eurostat (European Union), there were more than 142 million pigs, 76 million bovine animals, 60 million sheep, and 11 million goats in European countries by the end of December 2021.
Moreover, the large number of pet owners and rising expenditure on animal health are also driving the demand for animal medicines including veterinary antibiotics. According to the data published by HealthforAnimals, the population of pets in European nations is more than 215 million pet owners as compared to China which had more than 131 million pet owners in 2021. Furthermore, the increasing number of veterinary insurance holders is also anticipated to drive the market for various animal medicines including veterinary antibiotics.
However, stringent regulations and increasing antibiotic resistance among food-producing animals, along with the scarcity of veterinarians and skilled farm workers hinder the market growth.
Veterinary Antibiotics Market Trends
This section covers the major market trends shaping the Veterinary Antibiotics Market according to our research experts:
Penicillin Segment is Expected to Witness Significant Growth Over the Forecast Period
Penicillin is anticipated to dominate the market growth owing to the increasing veterinary diseases amongst livestock along with the rising adoption of penicillin in the management of various infectious diseases. According to the UK Veterinary Antibiotic Resistance and Sales, Surveillance Report, penicillin is also the most frequently prescribed antibiotic and it accounted for 46% of the total antibiotics prescribed for dogs and cats in 2020.
Moreover, the rising cases of veterinary diseases including respiratory, skeletal, urinary, skin, and bacterial infections are also driving the market growth. According to the report published by US Department of Agriculture (Wildlife Services), the number of rabies cases in animals in the United States increased from 4,055 to 4,090 during 2017 to 2020. Furthermore, the easy availability of penicillin products as compared to the other antibiotics along with the growth initiatives of major players to effective use of anitiobiotics are also supporting the segment growth during the forecast period. For instance, in January 2022, ADM announced the launch of a customized antibiotic reduction program developed by Wisium, its premix and nutrition services business.
Therefore, the penicillin segment is expected to witness significant growth over the forecast period due to increasing veterinary diseases and easy availability of the products in the market.
North America is Expected to Dominate the Veterinary Antibiotics Market
North America is expected to dominate the market owing to factors such as the increasing number of livestock and companion animals in the region. Moreover, increasing expenditure on animal health is also anticipated to support market growth. According to the study published by American Pet Products Association, in 2022, more than 90.5 million families owned a pet the number increased by 67% as compared to the number of pet owners in the year 2019. Furthermore, the increasing utilization of animal-based meat and high demand it is anticipated to drive the demand for animal feeds and medicines including veterinary antibiotics during the forecast period.
An increase in the number of veterinary clinics, the presence of key players in the region, and the growing awareness about veterinary diseases in livestock and companion animal owners are among the key factors which contribute to the growth of the studied market in North America. According to the report published by the American Veterinary Medical Association, more than 121,461 veterinarians were practicing in around 28,000-30,000 veterinary practices in the United States in the year 2021. Also, the new product by key players in the region is also responsible for the growth of the market. For instance, in October 2022, Huvepharma Inc. announced the relaunch of PoultrySulfa (sulfamerazine, sulfamethazine and sulfaquinoxaline), the only FDA-approved triple-sulfa veterinary product available to the animal health market in the United States.
Therefore, the increasing number of livestock and companion animals in the region, increase in the number of veterinary clinics, and new product launches are estimated to support the market growth in the region.
Veterinary Antibiotics Industry Overview
The veterinary antibiotics market is moderately consolidated in nature due to the presence of key companies operating on global as well as regional levels. The competitive landscape includes an analysis of a few international as well as local companies which hold market shares and are well known. include Boehringer Ingelheim International GmbH., Zoetis Services LLC., Elanco, Merck & Co., Inc., Phibro Animal Health Corporation., Virbac, Ceva, Dechra Pharmaceuticals PLC, Huvepharma NV, Vetoquinol, among others.
Veterinary Antibiotics Market Leaders
-
Zoetis Services LLC.
-
Phibro Animal Health Corporation
-
Ceva
-
Merck & Co., Inc.
-
Elanco
*Disclaimer: Major Players sorted in no particular order
Veterinary Antibiotics Market News
- In July 2022, Krka launched Cladaxxa which helps to treat respiratory, digestive, urinary, skin, and dental infections in dogs and cats.
- In July 2021, Virbac announced the launch of Tulissin 25 (tulathromycin injection) injectable solution and Tulissin 100 (tulathromycin injection) injectable solution for use in cattle and swine in the market.
Veterinary Antibiotics Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Pet & Livestock Ownership
4.2.2 Increasing Incidence of Livestock Diseases
4.2.3 Rising Focus On Animal-Only Antibiotics
4.3 Market Restraints
4.3.1 Stringent Regulations and Increasing Antibiotic Resistance Among Food-Producing Animals
4.3.2 Scarcity of Veterinarians and Skilled Farm Workers
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Animal Type
5.1.1 Poultry
5.1.2 Pigs
5.1.3 Cattle
5.1.4 Sheep & Goats
5.1.5 Companion Animals
5.1.6 Other Animal Types
5.2 By Drug Class
5.2.1 Tetracyclines
5.2.2 Penicillin
5.2.3 Sulfonamides
5.2.4 Macrolides
5.2.5 Other Drug Classes
5.3 By Dosage Form
5.3.1 Oral Powder
5.3.2 Oral Solutions
5.3.3 Injections
5.3.4 Other Dosage Forms
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Boehringer Ingelheim International GmbH.
6.1.2 Zoetis Services LLC.
6.1.3 Elanco
6.1.4 Merck & Co., Inc.
6.1.5 Phibro Animal Health Corporation.
6.1.6 Virbac
6.1.7 Ceva
6.1.8 Dechra Pharmaceuticals PLC
6.1.9 Huvepharma NV
6.1.10 Vetoquinol
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Veterinary Antibiotics Industry Segmentation
As per the scope of the report, veterinary antibiotics are primarily used to treat infectious diseases as well as preventative treatment for livestock and companion animals. The veterinary antibiotics market is segmented by Animal Type (Poultry, Pigs, Cattle, Sheep & Goats, Companion Animals, and Other Animal Types), Drug Class (Tetracyclines, Penicillin, Sulfonamides, Macrolides, and Other Drug Classes), Dosage Form (Oral Powder, Oral Solutions, Injections, and Other Dosage Forms), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
| By Animal Type | |
| Poultry | |
| Pigs | |
| Cattle | |
| Sheep & Goats | |
| Companion Animals | |
| Other Animal Types |
| By Drug Class | |
| Tetracyclines | |
| Penicillin | |
| Sulfonamides | |
| Macrolides | |
| Other Drug Classes |
| By Dosage Form | |
| Oral Powder | |
| Oral Solutions | |
| Injections | |
| Other Dosage Forms |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Veterinary Antibiotics Market Research FAQs
What is the current Veterinary Antibiotics Market size?
The Veterinary Antibiotics Market is projected to register a CAGR of 3.9% during the forecast period (2024-2029)
Who are the key players in Veterinary Antibiotics Market?
Zoetis Services LLC., Phibro Animal Health Corporation, Ceva, Merck & Co., Inc. and Elanco are the major companies operating in the Veterinary Antibiotics Market.
Which is the fastest growing region in Veterinary Antibiotics Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Veterinary Antibiotics Market?
In 2024, the North America accounts for the largest market share in Veterinary Antibiotics Market.
What years does this Veterinary Antibiotics Market cover?
The report covers the Veterinary Antibiotics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Veterinary Antibiotics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Veterinary Antibiotics Industry Report
Statistics for the 2024 Veterinary Antibiotics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Veterinary Antibiotics analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
